US Patent Issued to Innovstone Therapeutics on July 28 for "Compound having anti-tumor activity and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,252, issued on July 28, was assigned to Innovstone Therapeutics Ltd. (Shanghai).

"Compound having anti-tumor activity and use thereof" was invented by Yunlong Song (Shanghai), Wenqing Xu (Shanghai), Hongyan Kou (Shanghai), Yongzhao Mu (Shanghai), Qun Dang (Shanghai), Pan Li (Shanghai), Zhou Yin (Shanghai), Jianbin Ma (Shanghai), Xiaodan Fu (Shanghai), Xin Cai (Shanghai) and Yan Li (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a compound having anti-tumor activity and a use thereof. As a PRMT5 inhibitor, the compound has a structure represented by formula (I). Experiments have confirmed that these compounds have strong inhibito...